Search

Search Constraints

You searched for: Author/Creator Castagnetti, Fausto

Search Results

1. A population‐based study of chronic myeloid leukemia patients treated with imatinib in first line. Issue 1 (18th November 2016)

2. Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart. Issue 3 (17th April 2019)

3. Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis. Issue 7 (28th April 2018)

4. Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome. (7th February 2017)

5. COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. (11th October 2021)

7. Dasatinib first-line: Multicentric Italian experience outside clinical trials. (January 2016)

9. DNA Methyltransferase 1 Drives Transcriptional Down‐Modulation of β Catenin Antagonist Chibby1 Associated With the BCR‐ABL1 Gene of Chronic Myeloid Leukemia. Issue 4 (April 2015)

10. Favorable outcome of chronic myeloid leukemia co‐expressing e13a2 and e14a2 transcripts, treated with nilotinib. Issue 4 (23rd July 2020)